Log in to save to my catalogue

Prospective testing of clinical Cerenkov luminescence imaging against standard-of-care nuclear imagi...

Prospective testing of clinical Cerenkov luminescence imaging against standard-of-care nuclear imagi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9149092

Prospective testing of clinical Cerenkov luminescence imaging against standard-of-care nuclear imaging for tumour location

About this item

Full title

Prospective testing of clinical Cerenkov luminescence imaging against standard-of-care nuclear imaging for tumour location

Publisher

London: Nature Publishing Group UK

Journal title

Nature biomedical engineering, 2022-05, Vol.6 (5), p.559-568

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

In oncology, the feasibility of Cerenkov luminescence imaging (CLI) has been assessed by imaging superficial lymph nodes in a few patients undergoing diagnostic
18
F-fluoro-2-deoxyglucose (
18
F-FDG) positron emission tomography/computed tomography (PET/CT). However, the weak luminescence signal requires the removal of ambient light. He...

Alternative Titles

Full title

Prospective testing of clinical Cerenkov luminescence imaging against standard-of-care nuclear imaging for tumour location

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9149092

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9149092

Other Identifiers

ISSN

2157-846X

E-ISSN

2157-846X

DOI

10.1038/s41551-022-00876-4

How to access this item